These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
730 related articles for article (PubMed ID: 16963145)
1. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems. Dong WY; Körber M; López Esguerra V; Bodmeier R J Control Release; 2006 Oct; 115(2):158-67. PubMed ID: 16963145 [TBL] [Abstract][Full Text] [Related]
2. Injectable in situ forming depot systems: PEG-DAE as novel solvent for improved PLGA storage stability. Schoenhammer K; Petersen H; Guethlein F; Goepferich A Int J Pharm; 2009 Apr; 371(1-2):33-9. PubMed ID: 19135512 [TBL] [Abstract][Full Text] [Related]
3. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles. Kranz H; Bodmeier R Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569 [TBL] [Abstract][Full Text] [Related]
4. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine. Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030 [TBL] [Abstract][Full Text] [Related]
5. Development of an in situ forming PLGA drug delivery system I. Characterization of a non-aqueous protein precipitation. Körber M; Bodmeier R Eur J Pharm Sci; 2008 Nov; 35(4):283-92. PubMed ID: 18721875 [TBL] [Abstract][Full Text] [Related]
6. Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems. Tang Y; Singh J Int J Pharm; 2008 Jun; 357(1-2):119-25. PubMed ID: 18329202 [TBL] [Abstract][Full Text] [Related]
7. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method. Choi SH; Park TG Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477 [TBL] [Abstract][Full Text] [Related]
8. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions. Liu SQ; Tong YW; Yang YY Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542 [TBL] [Abstract][Full Text] [Related]
9. Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer. Liang R; Zhang R; Li X; Wang A; Chen D; Sun K; Liu W; Li Y Eur J Pharm Sci; 2013 Nov; 50(3-4):502-10. PubMed ID: 23994054 [TBL] [Abstract][Full Text] [Related]
10. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour. Unger F; Wittmar M; Morell F; Kissel T Biomaterials; 2008 May; 29(13):2007-14. PubMed ID: 18262641 [TBL] [Abstract][Full Text] [Related]
11. A novel in situ forming drug delivery system for controlled parenteral drug delivery. Kranz H; Bodmeier R Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049 [TBL] [Abstract][Full Text] [Related]
12. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone. da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313 [TBL] [Abstract][Full Text] [Related]
13. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles. Ganea GM; Sabliov CM; Ishola AO; Fakayode SO; Warner IM J Nanosci Nanotechnol; 2008 Jan; 8(1):280-92. PubMed ID: 18468072 [TBL] [Abstract][Full Text] [Related]
14. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
15. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer. Ahmed AR; Elkharraz K; Irfan M; Bodmeier R Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of highly-magnetic biodegradable poly(d,l-lactide-co-glycolide) nanospheres. Liu X; Kaminski MD; Chen H; Torno M; Taylor L; Rosengart AJ J Control Release; 2007 May; 119(1):52-8. PubMed ID: 17350131 [TBL] [Abstract][Full Text] [Related]
17. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles. Packhaeuser CB; Kissel T J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938 [TBL] [Abstract][Full Text] [Related]
18. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
19. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems. Luan X; Bodmeier R J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer. Chae GS; Lee JS; Kim SH; Seo KS; Kim MS; Lee HB; Khang G Int J Pharm; 2005 Sep; 301(1-2):6-14. PubMed ID: 16024190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]